Malignant Pancreatic Neoplasm — Trials

Malignant Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,629 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 903
Recruiting: 504
Ph III recruiting: 46
Growth YoY: +21.9%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%
Trials / 1,000 deaths: 18.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (516)

clinicaltrialsPublishedShowing 201–207 of 207 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00767273	Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx	completed	N/A	30	Stanford UniversityOTHER	1	Jun 11, 2012	clinicaltrials
NCT00639314	Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy	completed	N/A	130	Wakayama Medical UniversityOTHER	1	Jun 27, 2011	clinicaltrials